January 2024

Extended-release ML-007 was evaluated for safety, tolerability, and pharmacokinetic profile in healthy volunteers across several dosing regimens, alone and when co-administered with an extended-release muscarinic antagonist Extended-release ML-007 was well tolerated at all doses including doses at a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: